|
US6248713B1
(en)
*
|
1995-07-11 |
2001-06-19 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
US6037324A
(en)
*
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
ATE363658T1
(de)
|
1996-07-25 |
2007-06-15 |
Biogen Idec Inc |
Molekülmodell für vla-4-inhibitoren
|
|
US6686350B1
(en)
|
1996-07-25 |
2004-02-03 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
US6221888B1
(en)
|
1997-05-29 |
2001-04-24 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
|
US6903075B1
(en)
|
1997-05-29 |
2005-06-07 |
Merck & Co., Inc. |
Heterocyclic amide compounds as cell adhesion inhibitors
|
|
US6291511B1
(en)
|
1997-05-29 |
2001-09-18 |
Merck & Co., Inc. |
Biarylalkanoic acids as cell adhesion inhibitors
|
|
EP1017382B1
(en)
*
|
1997-05-29 |
2006-03-01 |
Merck & Co., Inc. (a New Jersey corp.) |
Biarylalkanoic acids as cell adhesion inhibitors
|
|
JP2002501518A
(ja)
*
|
1997-05-30 |
2002-01-15 |
セルテック セラピューティックス リミテッド |
抗炎症性チロシン誘導体
|
|
US6291453B1
(en)
|
1997-07-31 |
2001-09-18 |
Athena Neurosciences, Inc. |
4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6939855B2
(en)
|
1997-07-31 |
2005-09-06 |
Elan Pharmaceuticals, Inc. |
Anti-inflammatory compositions and method
|
|
US6583139B1
(en)
|
1997-07-31 |
2003-06-24 |
Eugene D. Thorsett |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6559127B1
(en)
|
1997-07-31 |
2003-05-06 |
Athena Neurosciences, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
AR016133A1
(es)
*
|
1997-07-31 |
2001-06-20 |
Wyeth Corp |
Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
|
|
US7030114B1
(en)
|
1997-07-31 |
2006-04-18 |
Elan Pharmaceuticals, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6362341B1
(en)
|
1997-07-31 |
2002-03-26 |
Athena Neurosciences, Inc. |
Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6492421B1
(en)
|
1997-07-31 |
2002-12-10 |
Athena Neurosciences, Inc. |
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6489300B1
(en)
|
1997-07-31 |
2002-12-03 |
Eugene D. Thorsett |
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6423688B1
(en)
|
1997-07-31 |
2002-07-23 |
Athena Neurosciences, Inc. |
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
DE19741235A1
(de)
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
DE19741873A1
(de)
*
|
1997-09-23 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
US6069163A
(en)
*
|
1997-10-21 |
2000-05-30 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
|
BR9813331A
(pt)
*
|
1997-10-31 |
2000-08-22 |
Aventis Pharma Ltd |
Composto, uso do mesmo, composição farmacêutica, processo para o tratamento de um paciente humano ou animal não humano que sofra ou esteja sujeito a condições que possam ser melhoradas pela administração de um inibidor da adesão celular mediada pela a4b1, e, resina
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
AU1415099A
(en)
*
|
1997-11-18 |
1999-06-07 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
US6020347A
(en)
*
|
1997-11-18 |
2000-02-01 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
DE19751251A1
(de)
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
US6191171B1
(en)
|
1997-11-20 |
2001-02-20 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
US6090841A
(en)
*
|
1997-11-21 |
2000-07-18 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
|
AU751950B2
(en)
*
|
1997-11-24 |
2002-09-05 |
Merck & Co., Inc. |
Substituted beta-alanine derivatives as cell adhesion inhibitors
|
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
|
US6407065B1
(en)
|
1998-01-23 |
2002-06-18 |
Novartis Ag |
VLA-4 antagonists
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
GB9805655D0
(en)
|
1998-03-16 |
1998-05-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6521626B1
(en)
|
1998-03-24 |
2003-02-18 |
Celltech R&D Limited |
Thiocarboxamide derivatives
|
|
WO1999054321A1
(en)
*
|
1998-04-21 |
1999-10-28 |
Aventis Pharma Limited |
Substituted diamines and their use as cell adhesion inhibitors
|
|
DE19821483A1
(de)
|
1998-05-14 |
1999-11-18 |
Hoechst Marion Roussel De Gmbh |
Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
HUP0102255A3
(en)
|
1998-05-28 |
2001-12-28 |
Biogen Idec Ma Inc Cambridge |
Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use
|
|
GB9811969D0
(en)
*
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9814414D0
(en)
|
1998-07-03 |
1998-09-02 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
AU1915399A
(en)
*
|
1998-07-10 |
2000-02-01 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
GB9916374D0
(en)
|
1998-07-23 |
1999-09-15 |
Zeneca Ltd |
Chemical compounds
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9821222D0
(en)
|
1998-09-30 |
1998-11-25 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9825652D0
(en)
|
1998-11-23 |
1999-01-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9826174D0
(en)
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9828074D0
(en)
*
|
1998-12-18 |
1999-02-17 |
Glaxo Group Ltd |
Therapeutically useful compounds
|
|
ES2297943T3
(es)
|
1998-12-23 |
2008-05-01 |
Aventis Pharma Limited |
Dihidro-benzo(1,4)oxacinas y tetrahidroquinoxalinas.
|
|
US6407066B1
(en)
|
1999-01-26 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
DE19922462A1
(de)
|
1999-05-17 |
2000-11-23 |
Aventis Pharma Gmbh |
Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
US6518283B1
(en)
|
1999-05-28 |
2003-02-11 |
Celltech R&D Limited |
Squaric acid derivatives
|
|
BR0012068A
(pt)
*
|
1999-06-30 |
2002-05-14 |
Daiichi Seiyaku Co |
Compostos inibidores de vla-4
|
|
US6756378B2
(en)
|
1999-06-30 |
2004-06-29 |
Pharmacopeia Drug Discovery, Inc. |
VLA-4 inhibitor compounds
|
|
RU2264386C2
(ru)
*
|
1999-06-30 |
2005-11-20 |
Дайити Фармасьютикал Ко., Лтд. |
Соединения ингибиторы vla-4
|
|
GEP20053477B
(en)
*
|
1999-08-13 |
2005-03-25 |
Biogen Inc |
Cell Adhesion Inhibitors and Pharmaceutical Compositions Containing Them
|
|
US6534513B1
(en)
|
1999-09-29 |
2003-03-18 |
Celltech R&D Limited |
Phenylalkanoic acid derivatives
|
|
JP2003517023A
(ja)
|
1999-12-16 |
2003-05-20 |
バイオジェン インコーポレイテッド |
中枢神経系の虚血性損傷または出血性損傷を、抗α４インテグリンアンタゴニストを用いて処置する方法
|
|
US6455539B2
(en)
|
1999-12-23 |
2002-09-24 |
Celltech R&D Limited |
Squaric acid derivates
|
|
EP1244656A1
(en)
*
|
1999-12-28 |
2002-10-02 |
Pfizer Products Inc. |
Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
|
|
AU2001248553A1
(en)
|
2000-04-17 |
2001-10-30 |
Celltech R And D Limited |
Enamine derivatives as cell adhesion molecules
|
|
US6403608B1
(en)
|
2000-05-30 |
2002-06-11 |
Celltech R&D, Ltd. |
3-Substituted isoquinolin-1-yl derivatives
|
|
US6545013B2
(en)
|
2000-05-30 |
2003-04-08 |
Celltech R&D Limited |
2,7-naphthyridine derivatives
|
|
WO2002004426A1
(en)
|
2000-07-07 |
2002-01-17 |
Celltech R & D Limited |
Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
|
|
EP1305291A1
(en)
|
2000-08-02 |
2003-05-02 |
Celltech R&D Limited |
3-substituted isoquinolin-1-yl derivatives
|
|
WO2002040021A2
(en)
*
|
2000-11-17 |
2002-05-23 |
Idenix (Cayman) Limited |
Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
|
|
US6875743B1
(en)
|
2000-11-28 |
2005-04-05 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
US7157487B2
(en)
|
2000-12-28 |
2007-01-02 |
Daiichi Pharmaceutical Co., Ltd. |
Vla-4 inhibitors
|
|
DE10111877A1
(de)
|
2001-03-10 |
2002-09-12 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
GB2377933A
(en)
|
2001-07-06 |
2003-01-29 |
Bayer Ag |
Succinic acid derivatives useful as integrin antagonists
|
|
DE10137595A1
(de)
|
2001-08-01 |
2003-02-13 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
|
|
EP1419396B1
(en)
*
|
2001-08-20 |
2009-05-06 |
Honeywell International Inc. |
Arcuately shaped flexures for micro-machined electromechanical system (mems) accelerometer device
|
|
AR038136A1
(es)
|
2002-01-24 |
2004-12-29 |
Merck Frosst Canada Inc |
Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
|
|
WO2004041279A1
(en)
|
2002-10-30 |
2004-05-21 |
Merck & Co., Inc. |
Gamma-aminoamide modulators of chemokine receptor activity
|
|
EP1650205B1
(en)
|
2003-07-24 |
2012-04-25 |
Daiichi Sankyo Company, Limited |
Cyclohexanecarboxylic acid compound
|
|
CN1301426C
(zh)
*
|
2003-08-19 |
2007-02-21 |
友达光电股份有限公司 |
窄边框设计的液晶显示面板及其制作方法
|
|
WO2005066124A1
(ja)
*
|
2003-12-26 |
2005-07-21 |
Daiichi Pharmaceutical Co., Ltd. |
ピロリジン誘導体の製造法
|
|
WO2005122379A2
(en)
*
|
2004-05-27 |
2005-12-22 |
The Regents Of The University Of California |
Alpha-4 beta-1 integrin ligands for imaging and therapy
|
|
US20060063828A1
(en)
*
|
2004-06-28 |
2006-03-23 |
Weingarten M D |
1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
|
|
US7196112B2
(en)
|
2004-07-16 |
2007-03-27 |
Biogen Idec Ma Inc. |
Cell adhesion inhibitors
|
|
US7140250B2
(en)
*
|
2005-02-18 |
2006-11-28 |
Honeywell International Inc. |
MEMS teeter-totter accelerometer having reduced non-linearty
|
|
EP1961750B1
(en)
|
2005-12-13 |
2013-09-18 |
Daiichi Sankyo Company, Limited |
Vla-4 inhibitory drug
|
|
EP2124996A4
(en)
|
2007-02-20 |
2010-03-24 |
Merrimack Pharmaceuticals Inc |
METHOD FOR TREATING MULTIPLE SCLEROSIS BY ADMINISTERING AN ALPHA FETOPROTEIN COMBINED WITH AN INTEGRINANT AGONIST
|
|
PT2229358E
(pt)
|
2007-12-14 |
2011-06-29 |
Pulmagen Therapeutics Asthma Ltd |
Indoles e sua utilização terapêutica
|
|
CA2721093A1
(en)
|
2008-04-11 |
2009-10-15 |
Merrimack Pharmaceuticals, Inc. |
Human serum albumin linkers and conjugates thereof
|
|
EP2346865B1
(en)
|
2008-09-22 |
2015-07-15 |
Merck Canada Inc. |
Indole derivatives as crth2 receptor antagonists
|
|
US20100204221A1
(en)
|
2009-02-09 |
2010-08-12 |
Hariprasad Vankayalapati |
Pyrrolopyrimidinyl axl kinase inhibitors
|
|
SG174134A1
(en)
|
2009-02-17 |
2011-10-28 |
Chiesi Farma Spa |
Triazolopyridine derivatives as p38 map kinase inhibitors
|
|
GB0902648D0
(en)
|
2009-02-17 |
2009-04-01 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
|
PE20120056A1
(es)
|
2009-02-24 |
2012-02-05 |
Merck Sharp & Dohme |
Derivados de indol como antagonistas del receptor crth2
|
|
KR20120118008A
(ko)
*
|
2009-12-18 |
2012-10-25 |
아이데닉스 파마슈티칼스, 인코포레이티드 |
5,5-융합 아릴렌 또는 헤테로아릴렌 간염 ｃ 바이러스 억제제
|
|
GB201009731D0
(en)
|
2010-06-10 |
2010-07-21 |
Pulmagen Therapeutics Inflamma |
Kinase inhibitors
|
|
WO2012031228A2
(en)
|
2010-09-02 |
2012-03-08 |
The Regents Of The University Of California |
Llp2a-bisphosphonate conjugates for osteoporosis treatment
|
|
EP2627178B1
(en)
|
2010-10-11 |
2018-05-02 |
Merck Sharp & Dohme Corp. |
Quinazolinone-type compounds as crth2 antagonists
|
|
EP2661428B1
(en)
|
2010-12-23 |
2017-06-07 |
Merck Sharp & Dohme Corp. |
Quinoxalines and aza-quinoxalines as crth2 receptor modulators
|
|
BR112013028430A2
(pt)
|
2011-05-04 |
2017-08-01 |
Merck Sharp & Dohme |
composto, composição farmacêutica, método para tratar uma doença ou condição mediada por tirosina quinase do baço (syk), e, uso de uma quantidade terapeuticamente eficiente do composto
|
|
PH12013502619A1
(en)
|
2011-06-17 |
2014-02-17 |
Merck Sharp & Dohme |
Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
|
|
WO2013052393A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
3-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
KR20140105459A
(ko)
|
2011-12-09 |
2014-09-01 |
키에시 파르마슈티시 엣스. 피. 에이. |
키나아제 억제제
|
|
BR112014013178A2
(pt)
|
2011-12-09 |
2017-06-13 |
Chiesi Farm Spa |
composto, composição farmacêutica e uso de um composto
|
|
DK2788349T3
(en)
|
2011-12-09 |
2017-01-30 |
Chiesi Farm Spa |
kinase inhibitors
|
|
RU2015151886A
(ru)
|
2013-06-06 |
2017-06-08 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Ингибиторы киназ
|
|
CN104817613A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd06及其制备方法和应用
|
|
CN104817615A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd05及其制备方法和应用
|
|
CN104817625A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd03及其制备方法和应用
|
|
CN104817622A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd04及其制备方法和应用
|
|
CN105294830A
(zh)
*
|
2014-06-18 |
2016-02-03 |
陈光健 |
一种二肽分子及其制备方法和应用
|
|
MX391259B
(es)
|
2015-10-14 |
2025-03-21 |
X Therma Inc |
Composiciones y métodos para reducir la formación de cristales de hielo.
|
|
TW201720828A
(zh)
|
2015-11-23 |
2017-06-16 |
赫孚孟拉羅股份公司 |
治療性化合物及組合物以及其使用方法
|
|
EP3394058B1
(en)
|
2015-12-23 |
2020-10-14 |
Chiesi Farmaceutici S.p.A. |
N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors
|
|
EP3394059B1
(en)
|
2015-12-23 |
2020-11-25 |
Chiesi Farmaceutici S.p.A. |
1-(3-tert-butyl-phenyl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro- naphthalen-1-yl)-urea derivatives and their use as p38 mapk inhibitors
|
|
AR107164A1
(es)
|
2015-12-23 |
2018-03-28 |
Chiesi Farm Spa |
INHIBIDORES DE QUINASA p38
|
|
JP7034942B2
(ja)
|
2016-05-05 |
2022-03-14 |
エフ．ホフマン－ラ ロシュ アーゲー |
ピラゾール誘導体、その組成物及び治療的使用
|
|
CN109890817B
(zh)
|
2016-09-06 |
2022-06-17 |
豪夫迈·罗氏有限公司 |
8-(氮杂环丁烷-1-基)-[1,2,4]三唑并[1,5-a]吡啶基化合物、其组合物和应用方法
|
|
US11111273B2
(en)
|
2016-11-11 |
2021-09-07 |
Zealand Pharma A/S |
Cyclic peptides multimers targeting alpha-4-beta-7 integrin
|
|
EP3562809B1
(en)
|
2016-12-29 |
2021-06-09 |
F. Hoffmann-La Roche AG |
Pyrazolopyrimidine compounds and methods of use thereof
|
|
WO2018140510A1
(en)
|
2017-01-25 |
2018-08-02 |
Biogen Ma Inc. |
Compositions and methods for treatment of stroke and other cns disorders
|
|
CN110494434B
(zh)
|
2017-03-14 |
2022-05-24 |
豪夫迈·罗氏有限公司 |
吡唑并氯苯基化合物、其组合物及其使用方法
|
|
KR20230079464A
(ko)
|
2017-05-10 |
2023-06-07 |
질랜드 파마 에이/에스 |
α4β7 인테그린을 타겟팅하는 호모데틱 사이클릭 펩타이드
|
|
WO2018215389A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
|
CN110678467B
(zh)
|
2017-05-22 |
2023-06-13 |
豪夫迈·罗氏有限公司 |
治疗化合物和组合物及其使用方法
|
|
US10364245B2
(en)
|
2017-06-07 |
2019-07-30 |
Chiesi Farmaceutici S.P.A. |
Kinase inhibitors
|
|
EP3740488A1
(en)
|
2018-01-15 |
2020-11-25 |
F. Hoffmann-La Roche AG |
Pyrazolopyrimidine compounds as jak inhibitors
|
|
KR102659859B1
(ko)
|
2018-10-30 |
2024-04-25 |
길리애드 사이언시즈, 인코포레이티드 |
알파4β7 인테그린의 억제를 위한 화합물
|
|
EP4541422A3
(en)
|
2018-10-30 |
2025-06-25 |
Gilead Sciences, Inc. |
Quinoline derivatives as alpha4beta7 integrin inhibitors
|
|
CN112969700B
(zh)
|
2018-10-30 |
2024-08-20 |
吉利德科学公司 |
作为α4β7整合素抑制剂的咪唑并吡啶衍生物
|
|
AU2019373242B2
(en)
|
2018-10-30 |
2023-07-13 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
EP3909952A4
(en)
|
2019-01-10 |
2023-01-25 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
SALTS OF HETEROCYCLIC COMPOUND AND USE THEREOF
|
|
CA3140024A1
(en)
|
2019-06-18 |
2020-12-24 |
Mark Edward Zak |
Pyrazolopyrimidine sulfone inhibitors of jak kinases and uses thereof
|
|
US20200399274A1
(en)
|
2019-06-18 |
2020-12-24 |
Genentech, Inc. |
Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereof
|
|
WO2020257143A1
(en)
|
2019-06-18 |
2020-12-24 |
Genentech, Inc. |
Pyrazolopyrimidine aryl ether inhibitors of jak kinases and uses thereof
|
|
KR102908219B1
(ko)
|
2019-08-14 |
2026-01-08 |
길리애드 사이언시즈, 인코포레이티드 |
알파 4 베타 7 인테그린의 저해용 화합물
|